A reverse-phase protein microarray-based screen identifies host signaling dynamics upon Burkholderia spp. infection

Area of Science:

• Microbiology
• Immunology
• Biochemistry

Background:

• Burkholderia bacteria cause severe infections in humans and animals, posing significant public health risks.
• Current therapeutic options are limited, highlighting the need for novel treatment strategies.
• Understanding host-pathogen interactions is crucial for identifying therapeutic targets.

Purpose of the Study:

• To investigate host protein expression and phosphorylation changes in macrophages during Burkholderia spp. infection.
• To identify novel host biomarkers and molecular signatures associated with Burkholderia infection using reverse-phase protein microarrays.
• To explore potential therapeutic targets by characterizing key host proteins involved in the immune response.

Main Methods:

• Utilized reverse-phase protein microarray technology to analyze host protein alterations.
• Infected macrophages with diverse Burkholderia spp. strains.
• Validated changes in 25 host proteins, focusing on eight for further characterization via immunoblotting.

Main Results:

• Identified alterations in the expression or phosphorylation of 25 host proteins during Burkholderia spp. infections.
• Observed increased phosphorylation of AMPK-α1, Src, and GSK3β.
• These findings suggest a critical role for these proteins in regulating the innate immune response to Burkholderia.

Conclusions:

• Host protein modulation, particularly phosphorylation of AMPK-α1, Src, and GSK3β, is central to the innate immune response against Burkholderia spp.
• Targeting these specific host proteins and their signaling pathways offers potential therapeutic avenues for treating Burkholderia infections.
• Further research into modulating these host factors could lead to the development of novel anti-Burkholderia therapies.